Abstract | INTRODUCTION: METHODS: Retrospective, multicenter, observational study, including patients with SCC and AC/ACS LACC patients treated with preoperative CT/RT followed by tailored radical surgery (RS) between 06/2002 and 05/2017. Clinical-pathological characteristics were compared between patients with SCC versus AC/ASC. A 1:3 ratio propensity score (PS) matching was applied to remove the variables imbalance between the two groups. RESULTS: After PS, 320 patients were included, of which 240 (75.0%) in the SCC group, and 80 (25.0%) in the AC/ASC group. Clinico-pathological and surgical baseline characteristics were balanced between the two study groups. Percentage of pathologic complete response was 47.5% in SCC patients versus 22.4% of AC/ASC ones (p < 0.001). With a median follow-up of 51 months (range:1-199), there were 54/240 (22.5%) recurrences in SCC versus 28/80 (35.0%) in AC/ASC patients (p = 0.027). AC/ASC patients experienced worse disease free (DFS), and overall survival (OS) compared to SCC patients (p = 0.019, and p = 0.048, respectively). In multivariate analysis, AC/ACS histotype, and FIGO stage were associated with worse DFS and OS. CONCLUSION: In LACC patients treated with CT/RT followed by RS, AC/ASC histology was associated with lower pathological complete response to CT/RT, and higher risk of recurrence and death compared with SCC patients. This highlights the need for specific therapeutic strategies based on molecular characterization to identify targets and develop novel treatments.
|
Authors | Francesco Legge, Nicolò Bizzarri, Valerio Gallotta, Luigi Pedone Anchora, Francesco Cosentino, Luigi Carlo Turco, Camilla Certelli, Gabriella Macchia, Vincenzo Valentini, Giovanni Scambia, Gabriella Ferrandina |
Journal | European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
(Eur J Surg Oncol)
Vol. 48
Issue 9
Pg. 2045-2052
(09 2022)
ISSN: 1532-2157 [Electronic] England |
PMID | 35450757
(Publication Type: Journal Article, Multicenter Study, Observational Study)
|
Copyright | Copyright © 2022 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved. |
Topics |
- Adenocarcinoma
(pathology)
- Carcinoma, Adenosquamous
(pathology)
- Carcinoma, Squamous Cell
(pathology)
- Chemoradiotherapy
- Female
- Humans
- Neoplasm Staging
- Propensity Score
- Retrospective Studies
- Uterine Cervical Neoplasms
(pathology)
|